Bristol-Myers Squibb to Take Part in Leerink Partners Rare Disease & Immuno-Oncology Roundtable Conference

NEW YORK–(BUSINESS WIRE)– Bristol-Myers
Squibb Company (NYSE:BMY) will take part in Leerink Partners Rare
Disease & Immuno-Oncology Roundtable Conference on Thursday, September
28, 2017, in New York. Thomas Lynch, chief scientific officer, will
answer questions about the company at 11:00 a.m. EDT.

Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.

Image may be NSFW.
Clik here to view.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170921005149/en/